References
- Rozendaal H. M. Clinical observations on the toxicology of boron hydrides. Industrial Hygiene and Occupational Medicine 1951; 4: 257–260
- Lowe H. J., Freeman G. Boron hydride intoxication in man. A.M.A. Archives of Industrial Health 1957; 16: 523–533
- Mindrum G. Pentaborane intoxication. Archives of Internal Medicine 1964; 114: 364–374
- Hart R. P., Silverman J. J., Garrettson L. K., Schulz S. C., Hamer R. M. Neuropsychological function following mild exposure to pentaborane. Am. J. Ind. Med. 1984; 6: 37–44
- Schulz S. C., Silverman J. J., Hart R. P., Garrettson L. K., Narasimhachari N., Hamer R. M., Stockman S. Increased VBRs following pentaborane exposure: Any clues for psychiatric research. presented at the Society of Biologic Psychiatry, Los Angeles, CA, May 2–6, 1984
- Naeger L. L., Leibman K. C. Mechanisms of decarborane toxicity. Toxicology and Applied Pharmacology 1972; 22: 517–527
- Merritt J. H., Schultz E. J. The effect of decaborane on the biosynthesis and metabolism of norepinephrine in the rat brain. Life Sciences 1966; 5: 27–32
- Merritt J. H., Schultz E. J., Wykes A. A. Effect of decaborane on the norepinephrine content of rat brain. Biochem. Pharmacol. 1964; 13: 1364–1366
- Wykes A. A., Landez J. H. The effect of decaborane and pentaborane on brain amines as influenced by pargyline hydrochloride and iproniazid phosphate. Federation Proc 1965; 24(1)194
- Merritt J. H., Sulkowski T. S. Inhibition of aromatic L-amino acid decarboxylation by decaborane. Biochem. Pharmacol. 1967; 16: 369–373
- Schayer R. W., Reilley M. A. Effect of decaborane on histamine formation in mice. J. Pharmacol. Exp. Ther. 1971; 177: 177–180
- Scott W. W., Cole H. D., Landez J. H., Wykes A. A. Transaminase inhibition by decaborane. Proc. Soc. Exp. Biol. Med. 1968; 127: 697–700
- Boyd R. E., Brennan P. T., Deng J. F., Rochester D. F., Spyker D. A. Strychnine poisoning: recovery from profound lactic acidosis, hyperthermia, and rhabdomyolysis. Amer. J. Med. 1983; 74: 507–512
- Posner J. B., Plum F. Protection of CSF pH and brain function during severe metabolic acidosis. Transactions Amer. Neuro. Assoc 1966; 91: 38–43
- Parker W. A., Shearer C. A. Phenytoin hepatotoxicity: a case report and review. Neurology 1979; 19(2)175–178
- Cronstock C. C., Oberst F. W. Median detectable concentration of diborane, pentaborane, and decaborane by odor for man, Chemical Corps. Medical Laboratories Research. August, 1953, Report #206
- Threshold Limit Values for 1963. American Conference of Government Industrial Hygienists. 1963. Cincinatti, OTTo, 1014 Broadway
- Levinskas G. J. Toxicology of boron compounds. Boron, Metaloboron Compounds and Boranes, R. H. Adams. Interscience, New York 1964; 712–737
- Long J. E., Levinskas G. J., Hill W. H., Sviberly J. L. Gas-mask protection against diborane, pentaborane, and mixtures of boranes. A.M.A. Arch. Indust. Health 1957; 16: 383–402
- Schectoer W. H. Toxicity of high-energy fules. A.M.A. Arch. Indust. Health 1958; 17: 362–366